BTSC

 
Common Stock Alternative Reporting
OTC Pink Current Information
Verified Company Profile 8/15/2017
Contact Info
  • 910 16th Street Mall
  • #412
  • Denver, CO 80202

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Not Available
Latest Report Jun 30, 2017 Quarterly Report
CIK 0001094735
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: CO, USA
Year of Inc. 2004
Employees 5 a/o Aug 14, 2017
Company Officers/Contacts
Joel Schneider CEO, CFO
Company Directors
Not Available
Company Notes
  • Formerly=Tulip BioMed, Inc. until 3-2016
  • Formerly=Cell Bio-Systems, Inc. until 6-06
  • Formerly=Direct Music Group, Inc. until 4-04
  • Formerly=BMX Holdings Inc. until 2-03
  • Formerly=JLL Miami Enterprises, Inc. until 1-02
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Matheau J.W. Stout Esq.
400 E. Pratt St.
8th Floor
Baltimore, MD, 21202
United States

Investor Relations Firm
Not Available
BTSC Security Details
Share Structure
Market Value1 $46,059,972 a/o Sep 19, 2017
Authorized Shares 1,890,000,010 a/o Aug 14, 2017
Outstanding Shares 639,721,827 a/o Aug 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 233,330,221 a/o Aug 14, 2017
Par Value 0.001
Transfer Agent(s)
Signature Stock Transfer, Inc.
Shareholders
Shareholders of Record 415 a/o Aug 14, 2017
Short Selling Data
Short Interest 1,443,995 (2,482.99%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security